Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 143
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
HIV Med ; 17(2): 143-51, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26176591

RESUMEN

OBJECTIVES: HIV infection affects the central nervous system (CNS), frequently causing cognitive impairment. Hippocampal injury impedes the ability to transfer information into memory. Therefore, we aimed to examine neuronal injury and repair in the hippocampal formation in HIV encephalopathy. METHODS: We compared neuropathological findings in 14 autopsy cases after death from systemic complications of HIV infection and in 15 age-matched HIV-negative control cases after sudden death from nonneurological causes using immunohistochemistry. RESULTS: The density of apoptotic granule cells in the dentate gyrus was higher in HIV-infected than in control cases (P = 0.048). Proliferation of neural progenitor cells in the dentate gyrus was increased in HIV infection (P = 0.028), whereas the density of recently generated TUC-4 [TOAD (turned on after division)/Ulip/CRMP family 4]-expressing neurons in this region was not significantly elevated in HIV-infected cases (P = 0.13). HIV infection caused microglial activation and astrocytosis in the neocortex and hippocampal formation. Conversely, we were unable to detect more pronounced axonal injury in HIV-infected than in control cases. CONCLUSIONS: As in other infections involving the CNS, apoptosis of hippocampal neurons accompanied by microglial activation and astrocytosis is a prominent feature of HIV encephalopathy. The regenerative potential, assessed using the density of young neurons in the hippocampal dentate gyrus, in HIV infection appears to be lower than in acute bacterial meningitis and septic encephalitis.


Asunto(s)
Complejo SIDA Demencia/patología , Hipocampo/patología , Inmunohistoquímica/métodos , Microglía/patología , Complejo SIDA Demencia/mortalidad , Complejo SIDA Demencia/fisiopatología , Adulto , Anciano , Autopsia , Femenino , Hipocampo/virología , Humanos , Masculino , Microglía/virología , Persona de Mediana Edad
2.
Gene Ther ; 20(8): 797-806, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23324824

RESUMEN

Inflammation can be prevented in most inflammatory brain diseases, while tissue repair of the lesioned central nervous system (CNS) is still a major challenge. The CNS is difficult to access for protein therapeutics due to the blood-brain barrier. Here, we show that genetically engineered embryonic stem cell-derived microglia (ESdM) are a suitable therapeutic vehicle for neurotrophin-3 (NT3) in experimental autoimmune encephalomyelitis (EAE). The intravenously transplanted ESdM migrated into the inflammatory CNS lesions and engrafted there as microglial cells. EAE afflicted mice treated with ESdM that were genetically modified to express NT3 showed stable recovery from disease symptoms. The NT3-transduced ESdM created an anti-inflammatory cytokine milieu in the spinal cord and promoted neuronal sprouting. Furthermore, mice treated with NT3-transduced ESdM showed less axonal injury and reduced demyelination. Thus, genetically modified ESdM represent a suitable tool to introduce therapeutic neuroprotective and repair-promoting proteins into the CNS in neuroinflammatory diseases.


Asunto(s)
Enfermedades del Sistema Nervioso Central/genética , Enfermedades del Sistema Nervioso Central/terapia , Encefalomielitis Autoinmune Experimental/terapia , Inflamación/terapia , Neurotrofina 3/genética , Animales , Barrera Hematoencefálica/metabolismo , Ingeniería Celular , Enfermedades del Sistema Nervioso Central/patología , Lesión Axonal Difusa/genética , Lesión Axonal Difusa/metabolismo , Células Madre Embrionarias/trasplante , Encefalomielitis Autoinmune Experimental/genética , Encefalomielitis Autoinmune Experimental/patología , Humanos , Inflamación/genética , Inflamación/metabolismo , Ratones , Microglía/metabolismo , Microglía/patología , Neurotrofina 3/metabolismo , Médula Espinal/metabolismo
3.
Ann Oncol ; 22(9): 2080-2085, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21303800

RESUMEN

BACKGROUND: Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non-Hodgkin lymphoma confined to the central nervous system. In this article, we report the results of a pilot trial adding rituximab to the established regimen consisting of methotrexate, procarbazine, and lomustine (R-MCP). DESIGN AND METHODS: PCNSL patients ≥65 years without Karnofsky performance score (KPS) limit were included. R-MCP regimen consisted of rituximab (375 mg/m(2) i.v. on days -6, 1, 15, and 29), methotrexate (3 g/m(2) i.v., days 2, 16, and 30) followed by folinic rescue, procarbazine (60 mg/m(2) orally, days 2-11), and lomustine (110 mg/m(2) orally, day 2). A maximum of three 43-day cycles were applied. Primary end point was response to treatment obtained by magnetic resonance imaging. Secondary end points were overall survival (OS) and progression-free survival (PFS). RESULTS: Twenty-eight patients were included (median age 75, median KPS 60%). Best documented response: complete remission in 18 of 28 (64%), partial remission in 5 of 28 (18%), stable disease in 1 of 28 (4%), and progressive disease in 2 of 28 (7%) patients. Response was not assessed in two patients. Two treatment-associated deaths were observed. After a median follow-up of 36 months, the 3-year PFS and OS was 31%. CONCLUSION: R-MCP regimen is well tolerated and active in elderly patients with newly diagnosed PCNSL.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias del Sistema Nervioso Central/terapia , Linfoma no Hodgkin/terapia , Factores de Edad , Anciano , Anciano de 80 o más Años , Anticuerpos Monoclonales de Origen Murino/administración & dosificación , Anticuerpos Monoclonales de Origen Murino/efectos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Neoplasias del Sistema Nervioso Central/tratamiento farmacológico , Neoplasias del Sistema Nervioso Central/inmunología , Terapia Combinada , Femenino , Humanos , Lomustina/administración & dosificación , Lomustina/efectos adversos , Linfoma no Hodgkin/tratamiento farmacológico , Linfoma no Hodgkin/inmunología , Masculino , Metotrexato/administración & dosificación , Metotrexato/efectos adversos , Proyectos Piloto , Procarbazina/administración & dosificación , Procarbazina/efectos adversos , Rituximab , Análisis de Supervivencia
4.
Nat Med ; 7(12): 1356-61, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11726978

RESUMEN

Gene therapy in the central nervous system (CNS) is hindered by the presence of the blood-brain barrier, which restricts access of serum constituents and peripheral cells to the brain parenchyma. Expression of exogenously administered genes in the CNS has been achieved in vivo using highly invasive routes, or ex vivo relying on the direct implantation of genetically modified cells into the brain. Here we provide evidence for a novel, noninvasive approach for targeting potential therapeutic factors to the CNS. Genetically-modified hematopoietic cells enter the CNS and differentiate into microglia after bone-marrow transplantation. Up to a quarter of the regional microglial population is donor-derived by four months after transplantation. Microglial engraftment is enhanced by neuropathology, and gene-modified myeloid cells are specifically attracted to the sites of neuronal damage. Thus, microglia may serve as vehicles for gene delivery to the nervous system.


Asunto(s)
Trasplante de Médula Ósea , Marcación de Gen , Terapia Genética/métodos , Microglía/trasplante , Animales , Barrera Hematoencefálica , Células de la Médula Ósea/citología , Isquemia Encefálica/terapia , Diferenciación Celular , Vectores Genéticos , Proteínas Fluorescentes Verdes , Proteínas Luminiscentes/aislamiento & purificación , Masculino , Ratones , Ratones Endogámicos C57BL , Microglía/citología , Proteínas Recombinantes/aislamiento & purificación , Retroviridae/genética
5.
Brain ; 132(Pt 12): 3353-65, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19741051

RESUMEN

The effect of interferon-beta in multiple sclerosis is modest and many patients do not respond to treatment. To date, no single biomarker reliably correlates with responsiveness to interferon-beta in multiple sclerosis. In the present study, genome-wide expression profiling was performed in peripheral blood mononuclear cells from 47 multiple sclerosis patients treated with interferon-beta for a minimum of 2 years and classified as responders and non-responders based on clinical criteria. A validation cohort of 30 multiple sclerosis patients was included in the study to replicate gene-expression findings. Before treatment, interferon-beta responders and non-responders were characterized by differential expression of type I interferon-induced genes with overexpression of the type interferon-induced genes in non-responders. Upon treatment the expression of these genes remained unaltered in non-responders, but was strongly upregulated in responders. Functional experiments showed a selective increase in phosphorylated STAT1 levels and interferon receptor 1 expression in monocytes of non-responders at baseline. When dissecting this type I interferon signature further, interferon-beta non-responders were characterized by increased monocyte type I interferon secretion upon innate immune stimuli via toll-like receptor 4, by increased endogenous production of type I interferon, and by an elevated activation status of myeloid dendritic cells. These findings indicate that perturbations of the type I interferon signalling pathway in monocytes are related to lack of response to interferon-beta, and type I interferon-regulated genes may be used as response markers in interferon-beta treatment.


Asunto(s)
Resistencia a Medicamentos/inmunología , Interferón Tipo I/metabolismo , Interferón beta/farmacología , Monocitos/inmunología , Esclerosis Múltiple/tratamiento farmacológico , Esclerosis Múltiple/inmunología , Adulto , Biomarcadores/análisis , Biomarcadores/metabolismo , Células Cultivadas , Estudios de Cohortes , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Resistencia a Medicamentos/genética , Femenino , Perfilación de la Expresión Génica , Regulación de la Expresión Génica/inmunología , Humanos , Inmunidad Innata/genética , Inmunidad Innata/inmunología , Interferón Tipo I/análisis , Interferón beta/uso terapéutico , Masculino , Monocitos/metabolismo , Esclerosis Múltiple/genética , Estudios Prospectivos , Transducción de Señal/genética , Transducción de Señal/inmunología , Receptor Toll-Like 4/metabolismo , Regulación hacia Arriba/genética , Regulación hacia Arriba/inmunología
6.
Science ; 167(3918): 597-9, 1970 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-17781510

RESUMEN

Glass spherules, glass fragments, augite, ferroaugite, titanaugite, pyroxmangite, pigeonite, hypersthene, plagioclase, potassium feldspar, maskelynite, olivine, silica, ilmenite, TiO(2), "ferropseudobrookite," spinel, ulvöspinel, native iron, nickel-iron, troilite, and chlorapatite were analyzed with the electron microprobe. There are no indications of large-scale chemical differentiation, chemical weathering, or hydrous minerals. Contributions of meteoritic material to lunar surface rocks are small. Rocks with igneous textures originated from a melt that crystallized at or near the surface, and oxygen fugacities have been low. Shock features indicate that at least some surface material is impact-produced.

7.
Science ; 179(4068): 74-6, 1973 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-17731633

RESUMEN

A spinel troctolite and an anorthosite from the Apollo 16 landing site represent contrasting types of "primitive" lunar cumulates. The two rock types probably formed from the same parent magma type, a high-alumina magnesian basalt, with the troctolite forming earlier by crystal settling, and the anorthosite later, possibly by flotation.

8.
Science ; 209(4454): 420-2, 1980 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-7384817

RESUMEN

It has been widely assumed, especially in the absence of other explanations, that lung cancer and nasal sinus cancers observed among nickel smelter workers are the result of the carcinogenicity of nickel. Although there may be such influence, supplementary hypotheses are also possible. The nickeliferous ores from at least one major smelter in New Caledonia (excess numbers of cancers have been found in these smelter workers) are derived from serpentinized host rocks which contain large amounts of chrysotile asbestos. Analysis indicates that nickel ores from this area are heavily contaminated by these fibers. The deposits are mined for their nickel content, but workers may be exposed to the asbestos fibers contained in the deposits. Hygiene measures limited to the avoidance of nickel may be inadequate under such circumstances and should be reevaluated so as to prevent the inhalation of asbestos-containing dusts.


Asunto(s)
Neoplasias Pulmonares/inducido químicamente , Neoplasias/inducido químicamente , Níquel/envenenamiento , Enfermedades Profesionales/inducido químicamente , Humanos , Microscopía Electrónica , Nueva Caledonia , Níquel/análisis
16.
Mucosal Immunol ; 11(2): 536-548, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-28745327

RESUMEN

Once considered merely as a vehicle for spermatozoa, it is now clear that seminal plasma (SP) induces a variety of biological actions on the female reproductive tissues able to modulate the immune response against paternal antigens. To our knowledge, the influence of SP on the immune response against sexually transmitted pathogens has not been yet evaluated. We here analyzed whether the seminal vesicle fluid (SVF), which contributes almost 60% of the SP volume in mice, could modulate the immune response against herpes simplex virus type 2 (HSV-2). We found that SVF does not modify the course of primary infection, but markedly improved protection conferred by vaginal vaccination with inactivated HSV-2 against a lethal challenge. This protective effect was shown to be associated to a robust memory immune response mediated by CD4+ and CD8+ T cells in both the lymph nodes draining the vagina and the vaginal mucosa, the site of viral replication. In contrast with the widespread notion that SP acts as an immunosuppressive agent, our results suggest that SVF might improve the female immune response against sexually transmitted pathogens.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Genitales Femeninos/fisiología , Herpes Genital/inmunología , Herpesvirus Humano 2/inmunología , Membrana Mucosa/inmunología , Semen/inmunología , Enfermedades Virales de Transmisión Sexual/inmunología , Vacunas Virales/inmunología , Administración Intravaginal , Animales , Femenino , Genitales Femeninos/virología , Humanos , Memoria Inmunológica , Activación de Linfocitos , Masculino , Ratones , Ratones Endogámicos BALB C , Membrana Mucosa/virología , Vacunación , Vacunas Atenuadas
17.
J Clin Invest ; 98(11): 2648-55, 1996 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-8958230

RESUMEN

To circumvent the embryonic lethality of a complete deficiency in insulin-like growth factor 1 (IGF-1), we generated mice homozygous for a site-specific insertional event that created a mutant IGF-1 allele (igf1m). These mice have IGF-1 levels 30% of wild type yet survive to adulthood, thereby allowing physiological analysis of the phenotype. Miniaturized catheterization technology revealed elevated conscious blood pressure in IGF-1(m/m) mice, and measurements of left ventricular contractility were increased. Adenylyl cyclase activity was enhanced in IGF-1(m/m) hearts, without an increase in beta-adrenergic receptor density, suggesting that crosstalk between IGF-1 and beta-adrenergic signaling pathways may mediate the increased contractility. The hypertrophic response of the left ventricular myocardium in response to aortic constriction, however, was preserved in IGF-1(m/m) mice. We conclude that chronic alterations in IGF-1 levels can selectively modulate blood pressure and left ventricular function, while not affecting adaptive myocardial hypertrophy in vivo.


Asunto(s)
Adenilil Ciclasas/metabolismo , Presión Sanguínea , Hormona del Crecimiento/metabolismo , Factor I del Crecimiento Similar a la Insulina/deficiencia , Factor I del Crecimiento Similar a la Insulina/genética , Mutagénesis Insercional , Contracción Miocárdica , Hipófisis/metabolismo , Receptores Adrenérgicos beta/metabolismo , Alelos , Animales , Glucemia/metabolismo , Cartilla de ADN , Femenino , Hormona del Crecimiento/sangre , Factor I del Crecimiento Similar a la Insulina/biosíntesis , Masculino , Ratones , Ratones Mutantes , Mutagénesis Sitio-Dirigida , Reacción en Cadena de la Polimerasa , Caracteres Sexuales
18.
Opt Express ; 15(12): 7351-6, 2007 Jun 11.
Artículo en Inglés | MEDLINE | ID: mdl-19547058

RESUMEN

Microscopic investigations of UV-induced formation of laser damage on LiB(3)O(5) optical surfaces during long-term sum-frequency generation (SFG) uncovers a significant growth of a SiO(2)-amorphous layer spatially limited to the illuminated area. The layer gives rise to a catastrophic break-down of the LiB(3)O(5)-output surface upon long-term laser operation even at intensities far below the laser-induced damage threshold. The interaction of UV laser light, LiB(3)O(5) surface and foreign atoms in the ambient atmosphere is discussed in the frame of a two-step process for surface-damage formation.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA